| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/17/2009 | US7491810 Transgenic screen and method for screening modulators of brain-derived neurotrophic factor (BDNF) production |
| 02/17/2009 | US7491809 Polynucleotides encoding human cytokine receptor |
| 02/17/2009 | US7491808 HCV non-structural protein mutants and uses thereof |
| 02/17/2009 | US7491807 A DNA sequence encoding a methyl CpG binding endonuclease protien of a size between about 60 and 75 kilodaltons containing an amino-terminal methyl CpG-binding domain, an internal segment rich in positively charged amino acids and a carboxy-terminal catalytic domain, having deoxyribonuclease activity |
| 02/17/2009 | US7491806 Comprises nucleotide sequences coding maize, soybean or arabidopsis homeobox transcription factors for use in genome mapping, identification and analysis, plant breeding and preparation of constructs for generating transgenic plants |
| 02/17/2009 | US7491798 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 02/17/2009 | US7491700 Contacting a cell with a peptide compound capable of inducing a conformational change in Bcl-2; converting the Bcl-2 into a pro-apoptotic form |
| 02/17/2009 | US7491680 Device for chemical and biochemical reactions using photo-generated reagents |
| 02/17/2009 | US7491533 Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channel |
| 02/17/2009 | US7491529 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/17/2009 | US7491524 Antisense inhibitors of human RNase III; antisense therapy |
| 02/17/2009 | US7491521 Rhodococcus nitrile hydratase |
| 02/17/2009 | US7491513 Composition and method for treating lupus nephritis |
| 02/17/2009 | US7491512 recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein; from E. coli, or yeast cell; vectors, host cells; produce immunostimulants, immunosuppressants, agonists, antagonists, biodrugs |
| 02/17/2009 | US7491511 isolated nucleic acid encoding a fungal antigen from Candida albicans; antiallergenic reaction to fungi in a vertebrate; and diagnosing a disease caused by fungi in a vertebrate; desensitization therapy for vaccines; insoluble cytoplasmic membrane proteins, free of cell wall |
| 02/17/2009 | US7491508 termini grow efficiently in desired cell line; left terminus spans the 5' inverted terminal repeat, left terminus spans the E4 region and the 3' inverted terminal repeat; internal regions does not grow efficiently in the desired cell; adenovirus vectors use for gene therapy; culturing; vaccines |
| 02/17/2009 | US7491507 Using lactobacillus to ferment hypotensive agents comprised of milk protein amino acid sequences; treatment for hypertension |
| 02/17/2009 | US7491498 Stopping extension cycle in a sequence by synthesis reaction before the reaction has run to near or full completion; exposing to primer and polymerase, hybridizing, adding labelled nucleotide, then neutralizing; solid phase synthesis |
| 02/17/2009 | US7491495 Adhering nucleotide sequences to solid support; gene expression analysis |
| 02/17/2009 | US7491493 Method and kit for molecular identification of smallpox |
| 02/17/2009 | US7491492 Single polymorphisms, tandem repeats, deletions, translocations; PCR |
| 02/17/2009 | US7491402 Superantigens SMEZ-2, SPE-G, SPE-H and SPE-J and uses thereof |
| 02/17/2009 | US7491401 Lawsonia intracellularis vaccine |
| 02/17/2009 | US7491385 Polynucleotide gene expression construction; therapy of diseases caused by damage to excitable tissue; cardiovascular disorders therapy; antidiabetic agents; Parkinson's disease; antiepileptic agents; neurodegenerative agents |
| 02/17/2009 | CA2192260C Dna fragment encoding a protein involved in fatty aldehyde decarbonylase activity, recombinant molecules comprising said fragment and a method for obtaining transformed bacterial cells and plants |
| 02/17/2009 | CA2120629C Production of gamma linolenic acid by a .delta.6-desaturase |
| 02/12/2009 | WO2009021056A1 Method for generation and use of isotopic patterns in mass spectral data of simple organisms |
| 02/12/2009 | WO2009021031A2 Proximity ligation assay |
| 02/12/2009 | WO2009021000A2 Protein and dna sequence encoding a cold adapted subtilisin-like activity |
| 02/12/2009 | WO2009020932A2 In-situ hybridization to detect rna and dna markers |
| 02/12/2009 | WO2009020848A2 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 02/12/2009 | WO2009020771A2 Rnai agents comprising universal nucleobases |
| 02/12/2009 | WO2009020249A1 Method for modification of nucleotides in nucleic acid, and nucleic acid having modified nucleotide therein |
| 02/12/2009 | WO2008131807A3 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease |
| 02/12/2009 | WO2008131364A3 Methods of diagnosing alzheimer's disease and associated markers |
| 02/12/2009 | WO2008128144A3 Monoclonal antibody selecting system, and making and using thereof |
| 02/12/2009 | WO2008127317A3 Alternatively spliced pre-mrna transcripts as biomarkers in idiopathic neurodegenerative diseases |
| 02/12/2009 | WO2007057897A3 Pharmaceutical composition and method for regulating abnormal cellular proliferation |
| 02/12/2009 | US20090044296 Hrpn interactors and uses thereof |
| 02/12/2009 | US20090043087 DNA purification and recovery from high particulate and solids samples |
| 02/12/2009 | US20090043085 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 02/12/2009 | US20090043084 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 02/12/2009 | US20090043083 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 02/12/2009 | US20090043082 Microrna and methods for inhibiting same |
| 02/12/2009 | US20090042830 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 02/12/2009 | US20090042828 Nucleic acid with 1st sequence encoding antisense RNAi specific for targeting regions of copper zinc superoxide dismutase that cause inherited amyotrophic lateral sclerosis, and a 2nd sequence encoding a RNAi resistant replacement gene with silent mutations encoding messenger RNA resistant to cleavage |
| 02/12/2009 | US20090042798 T cell receptors and related materials and methods of use |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042789 Method for Improving Symptom of Mood Disorder |
| 02/12/2009 | US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity |
| 02/12/2009 | US20090042786 Kunitz-type recombinant inhibitor |
| 02/12/2009 | US20090042785 Compound with Affinity for the Cytotoxic T Lymphocyte-Associated Antigen (Ctla-4) |
| 02/12/2009 | US20090042780 Modified TGF-Beta Superfamily Polypeptides and Related Methods |
| 02/12/2009 | US20090042742 Attachment of molecules to surfaces |
| 02/12/2009 | US20090042733 Process for detecting or quantifying nucleic acids in a library |
| 02/12/2009 | US20090042732 Methods for simplifying microbial nucleic acids by chemical modification of cytosines |
| 02/12/2009 | US20090042302 Isolated Polynucleotides and Methods of Promoting a Morphology in a Fungus |
| 02/12/2009 | US20090042298 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells |
| 02/12/2009 | US20090042290 Method of modifying a macromolecule without prior extraction from a sample |
| 02/12/2009 | US20090042282 Preparation of protective antigen |
| 02/12/2009 | US20090042277 Nucleic acids encoding recombinant soluble endoproteases |
| 02/12/2009 | US20090042275 Novel plasmids and utilization thereof |
| 02/12/2009 | US20090042266 Treatment of cellulosic material and enzymes useful thererin |
| 02/12/2009 | US20090042252 Interferon-alpha polypeptides and conjugates |
| 02/12/2009 | US20090042250 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
| 02/12/2009 | US20090042247 N-acetylglucosaminyltransferase vb coding sequences, recombinant cells and methods |
| 02/12/2009 | US20090042233 Novel protein member of the ras/mapk pathway, antibodies thereof and methods and kits of using same |
| 02/12/2009 | US20090042216 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/12/2009 | US20090042205 Fluorescence detection of dna breaks using molecular oscillators |
| 02/12/2009 | US20090042202 Prostate-specific polypeptide pamp and encoding nucleic acid molecules |
| 02/12/2009 | US20090042194 Predicting a response to risperidone |
| 02/12/2009 | US20090042192 Universal amplification of fragmented rna |
| 02/12/2009 | US20090042188 Agent for Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Comprising Vdup1 Protein or Gene Encoding the Same, and a Method of Differentiating Hematopoietic Stem Cell Into Natural Killer Cell Using Thereof |
| 02/12/2009 | US20090042187 Compositions and methods for predicting outcome of treatment |
| 02/12/2009 | US20090042186 Mapping new sites for antibiotic action in the ribosome |
| 02/12/2009 | US20090042181 Expresion vector comprising hepatitis C viral sequences for use in development and evaluation of antiviral drugs; drug screening |
| 02/12/2009 | US20090041899 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 02/12/2009 | US20090041896 Use in treatment of paper pulp or animal feeds; enzyme is active over a wide range of temperature and of basic and acid pH |
| 02/12/2009 | US20090041889 Gene Encoding Protein With Vicinal Diketone or Diacetyl-Reducing Activity and Use Thereof |
| 02/12/2009 | US20090041862 Detecting disease association with aberrant glycogen synthase kinase 3beta expression |
| 02/12/2009 | US20090041809 Double-stranded locked nucleic acid compositions |
| 02/12/2009 | US20090041796 Surface protein of leptospira |
| 02/12/2009 | US20090041793 Immunostimulatory Compositions and Uses Thereof |
| 02/12/2009 | US20090041789 Monoclonal Antibodies and Single Chain Antibody Fragments Against Cell-Surface Prostate Specific Membrane Antigen |
| 02/12/2009 | US20090041782 Novel serotype streptococcus mutans and utilization of the same |
| 02/12/2009 | US20090041777 G-protein specific immunoglobulin targeting and treatment of viral disorders; Drug screening |
| 02/12/2009 | US20090041774 Haemophilus influenzae type IV pili |
| 02/12/2009 | US20090041769 Extracellular domain of CTLA4, with (a) methionine at position 27 and ending with aspartic acid at position 150 (b) an alanine at position 26 and ending with aspartic acid at position 150 ; binds CD80 and/or CD86 with greater avidity; lupus, lupus erythematosus, and lupus nephritis |
| 02/12/2009 | US20090041758 Modified binding molecules comprising connecting peptides |
| 02/12/2009 | US20090041754 Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein |
| 02/12/2009 | US20090041742 Human dnase ii |
| 02/12/2009 | CA2695505A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
| 02/12/2009 | CA2695369A1 In-situ hybridization to detect rna and dna markers |
| 02/11/2009 | EP2022559A2 Nucleic acid library or protein or peptide library |
| 02/11/2009 | EP2021506A2 Use of products of pcr amplification carrying elements of secondary structure to improve pcr-based nucleic acid detection |
| 02/11/2009 | EP2021472A2 Compounds and methods for modulating gene expression |
| 02/11/2009 | EP2021367A2 Development of follicle stimulating hormone agonists and antagonists in fish |
| 02/11/2009 | EP2021363A1 Polypeptides and polynucleotides encoding the same |
| 02/11/2009 | EP2021352A2 Treatment of protein misfolding |
| 02/11/2009 | EP2021351A2 Method for the synthesis of triazole-containing oligonucleotide derivatives |